Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors

被引:11
|
作者
Sperandio, David [1 ]
Tai, Vincent W. -F. [1 ]
Lohman, Julia [1 ]
Hirschbein, Bernie [1 ]
Mendonca, Rohan [1 ]
Lee, Chang-Sun [1 ]
Spencer, Jeffrey R. [1 ]
Janc, James [1 ]
Nguyen, Margaret [1 ]
Beltman, Jerlyn [1 ]
Sprengeler, Paul [1 ]
Scheerens, Heleen [1 ]
Lin, Tong [1 ]
Liu, Liang [1 ]
Gadre, Ashwini [1 ]
Kellogg, Alisha [1 ]
Green, Michael J. [1 ]
McGrath, Mary E. [1 ]
机构
[1] Celera Gen, San Francisco, CA 94080 USA
关键词
D O I
10.1016/j.bmcl.2006.04.088
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of novel [1,2,4]oxadiazoles and their structure-activity relationship (SAR) for the inhibition of tryptase and related serine proteases is presented. Elaboration of the P'-side afforded potent, selective, and orally bioavailable tryptase inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4085 / 4089
页数:5
相关论文
共 50 条
  • [41] Potent and selective azetidinone inhibitors of tryptase.
    Bisacchi, GS
    Bolton, SA
    Gaitonde, D
    Hartl, KS
    Huang, MH
    Jacobs, G
    Ogletree, ML
    Pi, ZL
    Schumacher, WA
    Slusarchyk, WA
    Sutton, J
    Treuner, U
    Zhang, ZX
    Zhao, GH
    Zahler, R
    Seiler, SM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U4 - U4
  • [42] Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity
    Leger, Paul R.
    Hu, Dennis X.
    Biannic, Berenger
    Bui, Minna
    Han, Xinping
    Karbarz, Emily
    Maung, Jack
    Okano, Akinori
    Osipov, Maksim
    Shibuya, Grant M.
    Young, Kyle
    Higgs, Christopher
    Abraham, Betty
    Bradford, Delia
    Cho, Cynthia
    Colas, Christophe
    Jacobson, Scott
    Ohol, Yamini M.
    Pookot, Deepa
    Rana, Payal
    Sanchez, Jerick
    Shah, Niket
    Sun, Michael
    Wong, Steve
    Brockstedt, Dirk G.
    Kassner, Paul D.
    Schwarz, Jacob B.
    Wustrow, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (10) : 5398 - 5420
  • [43] Discovery of potent and selective orally bioavailable β-substituted phenylalanine derived dipeptidyl peptidase IV inhibitors
    Edmondson, SD
    Mastracchio, A
    Duffy, JL
    Eiermann, GJ
    He, HB
    Ita, I
    Leiting, B
    Leone, JF
    Lyons, KA
    Makarewicz, AM
    Patel, RA
    Petrov, A
    Wu, JK
    Nancy, AT
    Weber, AE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3048 - 3052
  • [44] The discovery of potent, selective, and orally bioavailable PDE9 inhibitors as potential hypoglycemic agents
    DeNinno, Michael P.
    Andrews, Melissa
    Bell, Andrew S.
    Chen, Yue
    Eller-Zarbo, Cynthia
    Eshelby, Nan
    Etienne, John B.
    Moore, Dianna E.
    Palmer, Michael J.
    Visser, Michael S.
    Yu, Li J.
    Zavadoski, William J.
    Gibbs, E. Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (09) : 2537 - 2541
  • [45] Structure guided optimization of novel, selective, and orally bioavailable inhibitors of Pim kinases
    Nishiguchi, Gisele A.
    Burger, Matthew
    Han, Wooseok
    Lan, Jiong
    Atallah, Gordana
    Ding, Yu
    Mathur, Michelle
    Muller, Kristine
    Tamez, Victoriano
    Lindvall, Mika
    Bellamacina, Cornelia
    Garcia, Pablo
    Zavorotinskaya, Tatiana
    Feucht, Paul
    Langowski, John
    Zang, Richard
    Dai, Yumin
    Chan, Julie
    Holash, Jocelyn
    Huh, Kay
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [46] Discovery of Potent, Selective, and Orally Bioavailable DYRK2 Inhibitors for the Treatment of Prostate Cancer
    Yuan, Kai
    Xia, Fei
    Li, Qiannan
    Zheng, Mingming
    Shen, Hongtao
    Chen, Weijiao
    Yang, Huanaoyu
    Zhuang, Xujie
    Zhang, Xiao-Yu
    Xiao, Yibei
    Yang, Peng
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (23) : 16235 - 16256
  • [47] Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors
    Cox, Jason M.
    Harper, Bart
    Mastracchio, Anthony
    Leiting, Barbara
    Roy, Ranabir Sinha
    Patel, Reshma A.
    Wu, Joseph K.
    Lyons, Kathryn A.
    He, Huaibing
    Xu, Shiyao
    Zhu, Bing
    Thornberry, Nancy A.
    Weber, Ann E.
    Edmondson, Scott D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4579 - 4583
  • [48] Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
    Koltun, Dmitry O.
    Zilbershtein, Timur M.
    Migulin, Vasily A.
    Vasilevich, Natalya I.
    Parkhill, Eric Q.
    Glushkov, Andrei I.
    McGregor, Malcolm J.
    Brunn, Sandra A.
    Chu, Nancy
    Hao, Jia
    Mollova, Nevena
    LeungF, Kwan
    Chisholm, Jeffrey W.
    Zablocki, Jeff
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4070 - 4074
  • [49] Selective Inhibitors of the Mutant B-Raf Pathway: Discovery of a Potent and Orally Bioavailable Aminoisoquinoline
    Smith, Adrian L.
    DeMorin, Frenel F.
    Paras, Nick A.
    Huang, Qi
    Petkus, Jeffrey K.
    Doherty, Elizabeth M.
    Nixey, Thomas
    Kim, Joseph L.
    Whittington, Douglas A.
    Epstein, Linda F.
    Lee, Matthew R.
    Rose, Mark J.
    Babij, Carol
    Fernando, Manory
    Hess, Kristen
    Le, Quynh
    Beltran, Pedro
    Carnahan, Josette
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6189 - 6192
  • [50] Discovery of potent, selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors
    Xu, Jinyou
    Wei, Lan
    Mathvink, Robert J.
    Edmondson, Scott D.
    Eiermann, George J.
    He, Huaibing
    Leone, Joseph F.
    Leiting, Barbara
    Lyons, Kathryn A.
    Marsilio, Frank
    Patel, Reshma A.
    Patel, Sangita B.
    Petrov, Aleksandr
    Scapin, Giovanna
    Wu, Joseph K.
    Thornberry, Nancy A.
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (20) : 5373 - 5377